Attitude Survey about Adverse Drug Reactions Relief System for Pharmacists of Insurance Dispensing Pharmacies and Examination of Its Problems
- VernacularTitle:保険薬局の薬剤師を対象とした副作用救済制度についての意識調査およびその問題点の検討
- Author:
Shigeo AKIYAMA
1
;
Nobuyuki DOI
2
;
Miyoko ASANO
3
;
Shigeyasu FUKUZUMI
4
;
Shingo TAKAHASHI
5
;
Katsutoshi SUZUKI
6
;
Kenji OGAWA
7
;
Etsuko MIYAMOTO
8
Author Information
- Keywords: Adverse Drug Reaction Relief System; community pharmacy; pharmacist; community support system
- From:Japanese Journal of Drug Informatics 2020;22(2):101-107
- CountryJapan
- Language:Japanese
- Abstract: Objectives: “Adverse Drug Reaction Relief System” (hereinafter called the Relief System) has been established to provide prompt relief to patients experiencing health damage caused by adverse drug reactions. Since 2018, the Relief System has required community pharmacies that acquire additional points as local support system to actively report adverse drug reactions. Here, we investigated the recognition and utilization of the relief system among community pharmacists.Method: A questionnaire survey was conducted among community pharmacists between August 1 and September 30, 2019.Results: The survey achieved a response rate of 58.1%. The recognition rates of the relief system and Pharmaceuticals and Medical Devices Agency (PMDA) as its application destination were 98.9 and 74.5%, respectively. Of the community pharmacists, 2.6% had experience in utilizing the relief system; and 8.8% did not want to recommend the utilization of the relief system for patients mainly because of the “low recognition of the system” and “the complicated and troublesome preparation of the necessary documents such as medical certificates.” The community pharmacists who acquire additional points as local support system, compared with those who do not, achieved significantly higher rates in two items, including that for preparation of the documented procedures pertaining to adverse drug reactions.Conclusion: Despite the high recognition of the relief system among community pharmacists, the percentage of pharmacists with experience in actually utilizing the relief system and applying to the PMDA was low. One reason that the use of the relief system was not widespread was the low recognition particularly of the destination and procedures of reports on adverse drug reactions. In the future, educational campaigns to improve pharmacists’ comprehension of the relief system will be needed. Moreover, pharmacists must play a central role in enhancing the recognition of the public relief system and promoting medical safety.
